Literature DB >> 24648324

Concise review: Fragile X proteins in stem cell maintenance and differentiation.

Yue Li1, Xinyu Zhao.   

Abstract

Fragile X syndrome (FXS), the most common genetic form of autism spectrum disorder, is caused by deficiency of the fragile X mental retardation protein (FMRP). Despite extensive research and scientific progress, understanding how FMRP regulates brain development and function remains a major challenge. FMRP is a neuronal RNA-binding protein that binds about a third of messenger RNAs in the brain and controls their translation, stability, and cellular localization. The absence of FMRP results in increased protein synthesis, leading to enhanced signaling in a number of intracellular pathways, including the mTOR, mGLuR5, ERK, Gsk3β, PI3K, and insulin pathways. Until recently, FXS was largely considered a deficit of mature neurons; however, a number of new studies have shown that FMRP may also play important roles in stem cells, among them neural stem cells, germline stem cells, and pluripotent stem cells. In this review, we will cover these newly discovered functions of FMRP, as well as the other two fragile X-related proteins, in stem cells. We will also discuss the literature on the use of stem cells, particularly neural stem cells and induced pluripotent stem cells, as model systems for studying the functions of FMRP in neuronal development.
© 2014 AlphaMed Press.

Entities:  

Keywords:  Adult stem cells; Developmental biology; FMRP; Fragile X syndrome; Nervous system; Neural differentiation; Neural stem cell; Pluripotent stem cells; Stem cell plasticity

Mesh:

Substances:

Year:  2014        PMID: 24648324      PMCID: PMC4255947          DOI: 10.1002/stem.1698

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  95 in total

1.  Chemical induction of mGluR5- and protein synthesis--dependent long-term depression in hippocampal area CA1.

Authors:  K M Huber; J C Roder; M F Bear
Journal:  J Neurophysiol       Date:  2001-07       Impact factor: 2.714

Review 2.  New perspectives on the biology of fragile X syndrome.

Authors:  Tao Wang; Steven M Bray; Stephen T Warren
Journal:  Curr Opin Genet Dev       Date:  2012-02-28       Impact factor: 5.578

3.  Inhibition of GSK3β improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome.

Authors:  Weixiang Guo; Adeline C Murthy; Li Zhang; Eric B Johnson; Eric G Schaller; Andrea M Allan; Xinyu Zhao
Journal:  Hum Mol Genet       Date:  2011-11-02       Impact factor: 6.150

Review 4.  The fragile-X premutation: a maturing perspective.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Am J Hum Genet       Date:  2004-03-29       Impact factor: 11.025

Review 5.  Psychopharmacology in fragile X syndrome--present and future.

Authors:  Elizabeth Berry-Kravis; Kristina Potanos
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2004

6.  Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models.

Authors:  Jing Zhang; Lingfei Hou; Eric Klann; David L Nelson
Journal:  J Neurophysiol       Date:  2009-02-25       Impact factor: 2.714

Review 7.  The glial nature of embryonic and adult neural stem cells.

Authors:  Arnold Kriegstein; Arturo Alvarez-Buylla
Journal:  Annu Rev Neurosci       Date:  2009       Impact factor: 12.449

8.  The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP.

Authors:  Ilaria Napoli; Valentina Mercaldo; Pietro Pilo Boyl; Boris Eleuteri; Francesca Zalfa; Silvia De Rubeis; Daniele Di Marino; Evita Mohr; Marzia Massimi; Mattia Falconi; Walter Witke; Mauro Costa-Mattioli; Nahum Sonenberg; Tilmann Achsel; Claudia Bagni
Journal:  Cell       Date:  2008-09-19       Impact factor: 41.582

9.  Is metabotropic glutamate receptor 5 upregulated in prefrontal cortex in fragile X syndrome?

Authors:  Talakad G Lohith; Emily K Osterweil; Masahiro Fujita; Kimberly J Jenko; Mark F Bear; Robert B Innis
Journal:  Mol Autism       Date:  2013-05-24       Impact factor: 7.509

10.  Crosstalk among Epigenetic Pathways Regulates Neurogenesis.

Authors:  Emily M Jobe; Andrea L McQuate; Xinyu Zhao
Journal:  Front Neurosci       Date:  2012-05-08       Impact factor: 4.677

View more
  24 in total

1.  FXR proteins bring new perspectives to nucleoporins' homeostasis.

Authors:  Guillaume Holzer; Wolfram Antonin
Journal:  EMBO J       Date:  2020-09-11       Impact factor: 11.598

2.  Molecular mechanisms regulating impaired neurogenesis of fragile X syndrome human embryonic stem cells.

Authors:  Michael Telias; Yoav Mayshar; Ami Amit; Dalit Ben-Yosef
Journal:  Stem Cells Dev       Date:  2015-10-15       Impact factor: 3.272

3.  Fragile X Proteins FMRP and FXR2P Control Synaptic GluA1 Expression and Neuronal Maturation via Distinct Mechanisms.

Authors:  Weixiang Guo; Eric D Polich; Juan Su; Yu Gao; Devin M Christopher; Andrea M Allan; Min Wang; Feifei Wang; Guangfu Wang; Xinyu Zhao
Journal:  Cell Rep       Date:  2015-06-04       Impact factor: 9.423

Review 4.  SHANK family on stem cell fate and development.

Authors:  Xu Liu; Mengmeng Yuan; Benson Wui-Man Lau; Yue Li
Journal:  Cell Death Dis       Date:  2022-10-18       Impact factor: 9.685

5.  MDM2 inhibition rescues neurogenic and cognitive deficits in a mouse model of fragile X syndrome.

Authors:  Yue Li; Michael E Stockton; Ismat Bhuiyan; Brian E Eisinger; Yu Gao; Jessica L Miller; Anita Bhattacharyya; Xinyu Zhao
Journal:  Sci Transl Med       Date:  2016-04-27       Impact factor: 17.956

Review 6.  Human pluripotent stem cell models of Fragile X syndrome.

Authors:  Anita Bhattacharyya; Xinyu Zhao
Journal:  Mol Cell Neurosci       Date:  2015-11-27       Impact factor: 4.314

Review 7.  Intergenerational Metabolic Syndrome and Neuronal Network Hyperexcitability in Autism.

Authors:  Aileen Rivell; Mark P Mattson
Journal:  Trends Neurosci       Date:  2019-09-05       Impact factor: 13.837

8.  FXR1 expression domain in Wilms tumor.

Authors:  Hannah M Phelps; Janene M Pierce; Andrew J Murphy; Hernan Correa; Jun Qian; Pierre P Massion; Harold N Lovvorn
Journal:  J Pediatr Surg       Date:  2019-02-28       Impact factor: 2.545

9.  Novel fragile X syndrome 2D and 3D brain models based on human isogenic FMRP-KO iPSCs.

Authors:  Carlo Brighi; Federico Salaris; Alessandro Soloperto; Alessandro Rosa; Silvia Di Angelantonio; Federica Cordella; Silvia Ghirga; Valeria de Turris; Maria Rosito; Pier Francesca Porceddu; Chiara D'Antoni; Angelo Reggiani
Journal:  Cell Death Dis       Date:  2021-05-15       Impact factor: 8.469

Review 10.  Functional Integration of mRNA Translational Control Programs.

Authors:  Melanie C MacNicol; Chad E Cragle; Karthik Arumugam; Bruno Fosso; Graziano Pesole; Angus M MacNicol
Journal:  Biomolecules       Date:  2015-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.